Skip to main content

Table 2 AST profile of the selected Klebsiella pneumoniae isolates

From: Exploring the resistome, virulome, and mobilome of multidrug-resistant Klebsiella pneumoniae isolates: deciphering the molecular basis of carbapenem resistance

Strain

β lactams

Aminoglycosides

Fluoroquinolones

Combinations

Fosfomycin

Polymyxin

 

Penicillin

Cephalosporins

Carbapenems

 

AMP

FEP

CAZ

CTX

CRO

MEM

IMP

AK

CN

TOB

CIP

LEV

NOR

OFX

TZP

SXT

FOS

CT

 

kp5

R

R

R

R

R

R

R

R

S

R

R

S

R

R

R

R

R

S

XDR

kp6

R

R

R

R

R

R

R

R

R

R

R

R

R

R

R

R

S

S

XDR

kp10

R

R

R

R

R

R

S

S

I

I

R

R

R

R

I

R

S

S

MDR

kp47

R

R

R

R

R

R

R

R

R

R

R

R

R

I

R

R

S

S

MDR

kp54

R

R

R

R

R

R

R

R

R

R

R

R

R

R

R

R

S

S

XDR

kp58

R

R

R

R

R

R

R

S

S

R

R

R

R

R

R

R

S

S

MDR

kp106

R

R

R

R

R

R

R

R

R

R

R

R

R

R

R

R

S

S

XDR

kp126

R

R

R

R

R

R

R

S

S

S

I

I

S

R

R

R

S

S

MDR

kp127

R

R

R

R

R

R

R

S

S

S

S

I

I

R

R

R

S

S

MDR

kp128

R

R

R

R

R

R

R

R

R

S

I

I

R

R

R

R

S

S

MDR

  1. AMP Ampicillin, FEP Cefepime, CAZ Ceftazidime, CTX Cefotaxime, CRO Ceftriaxone, MEM Meropenem, IMP Imipenem, AK Amikacin, CN Gentamicin, TOB Tobramycin, CIP Ciprofloxacin, LEV Levofloxacin, NOR Norfloxacin, OFX Ofloxacin, TZP Ceftolozane/Tazobactam, SXT Trimethoprim/Sulfamethoxazole, FOS Fosfomycin, CT Colistin. Sensitive (Probably susceptible to ordinary dosage therapy), I: Intermediate (Likely to respond to high dosage therapy), R: Resistant (Unlikely to respond to high dosage therapy